Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04909463 · ClinicalTrials.gov registry record · NA
Effects of Using the Duracore Splinting Device on Patient Outcomes Related to Chest Trauma
A NA study, sponsored by CommonSpirit Health.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04909463: Clinical Trial NA study, sponsored by CommonSpirit Health.
NCT04909463 is a NA study that was terminated before completion, run by CommonSpirit Health. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04909463, a NA study, was terminated before completion, sponsored by CommonSpirit Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to use the Duracore splinting device to measure lung capacities of patients with rib fractures in control and experimental groups to determine if lung capacities improve with the splint.
Primary Outcome
Change in forced vital capacities over time using the device as compared to control groups
Interventions
- DEVICE Chest Splint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-12-04 |
| Est. Completion | 2021-07-30 |
| Phase | NA |
Why NCT04909463 stopped before completion
NCT04909463 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Chest Splint is the first listed.
NCT04909463 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04909463 about?
NCT04909463 is a clinical study titled "Effects of Using the Duracore Splinting Device on Patient Outcomes Related to Chest Trauma". The purpose of this study is to use the Duracore splinting device to measure lung capacities of patients with rib fractures in control and experimental groups to determine if lung capacities improve with the splint.
What is the current status of trial NCT04909463?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2020-12-04. Estimated completion is 2021-07-30.
What interventions are being tested in trial NCT04909463?
The interventions under investigation include: Chest Splint (DEVICE).
Who is sponsoring clinical trial NCT04909463?
This trial is sponsored by CommonSpirit Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04909463's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI